The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung
Author:
- 7 July 2021
- journal article
- editorial
- Published by Taylor & Francis in Tissue Barriers
- Vol. 9 (4) , 1937013
Abstract
Blood-gas barrier (BGB) or alveolar-capillary barrier is the primary tissue barrier affected by coronavirus disease 2019 (COVID-19). Comprising alveolar epithelial cells (AECs), endothelial cells (ECs) and the extracellular matrix (ECM) in between, the BGB is damaged following the action of multiple pro-inflammatory cytokines during acute inflammation. The infection of AECs and ECs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen behind COVID-19, triggers an inflammatory response at the BGB, inducing the release of interleukin 1 (IL-1), IL-6, tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), high mobility group box 1 (HMGB1), matrix metalloproteinases (MMPs), intercellular adhesion molecule-1 (ICAM-1) and platelet activating factor (PAF). The end result is the disassembly of adherens junctions (AJs) and tight junctions (TJs) in both AECs and ECs, AEC hyperplasia, EC pyroptosis, ECM remodeling and deposition of fibrin clots in the alveolar capillaries, leading to disintegration and thickening of the BGB, and ultimately, hypoxia. This commentary seeks to provide a brief account of how the BGB might become affected in COVID-19.Keywords
This publication has 49 references indexed in Scilit:
- Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthoodTissue Barriers, 2017
- Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cellsOncoTargets and Therapy, 2017
- In life there is death: How epithelial tissue barriers are preserved despite the challenge of apoptosisTissue Barriers, 2017
- Development and Maintenance of the Blood–Brain Barrier2017
- Hyperglycemia-Induced Modulation of the Physiognomy and Angiogenic Potential of Fibroblasts Mediated by Matrix Metalloproteinase-2: Implications for Venous Stenosis Formation Associated with Hemodialysis Vascular Access in Diabetic MilieuJournal of Vascular Research, 2016
- Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblastsRespiratory Research, 2016
- NF-κB inhibitors impair lung epithelial tight junctions in the absence of inflammationTissue Barriers, 2015
- Blood cells and endothelial barrier functionTissue Barriers, 2015
- Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological ConditionsBioMed Research International, 2014
- Development and Remodeling of the Vertebrate Blood-Gas BarrierBioMed Research International, 2012